Validation of a Connected Patch, an Alternative to Conventional Monitoring

Sponsor
CMC Ambroise Paré (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04344093
Collaborator
(none)
0
1
1
17.1
0

Study Details

Study Description

Brief Summary

The hypothesis is that this connected patch could be used in surgical departments to detect early a cardiovascular or respiratory complication and therefore to treat it without delay. However, it has not been validated in a hospital setting; that is the purpose of this project. This step of validating the connected monitoring object is required in different places: post-interventional surveillance room that approaches a conventional hospital room, and operating room where artifacts are numerous. Validation will be done by comparing data from General Electric's conventional monitors, with data from patches.

Condition or Disease Intervention/Treatment Phase
  • Device: Patch validation
N/A

Detailed Description

When patients operated on outside intensive care or intensive care units are hospitalized, vital signs are collected intermittently by various conventional devices. During the follow-up period of these patients, it is possible that abnormal vital signs that may identify clinical deterioration may appear a few minutes to a few hours before a serious adverse event (infection etc.) occurs. These signals often go unnoticed due to infrequent monitoring.

The establishment of teams to ensure a rapid response would improve the safety of hospitalized patients for whom the detection of abnormal vital signs predictive of clinical deterioration would generate an alarm. This system is based on the identification of patients at risk and the rapid intervention of the team.

One of the crucial issues is therefore the speed of the alarm and its reliability.

The evolution of electronic technology offers the possibility of using inexpensive portable devices (connected patches) that can provide information on vital signs in real time. Vital signs collected by these devices could be analyzed to predict clinical deterioration prior to hospital staff visits, especially at night and on weekends when staffing levels are generally lower.

The connected patch used in this research is the Devinnova company's device "myAngel VitalSigns". The long-term objective would be to be able to use this connected patch in surgical departments to detect early a complication, particularly of a cardiovascular or respiratory nature, and therefore to treat it without wasting time. However, it has not been validated in a hospital setting; that is the purpose of the project.

The objective of this research is therefore to validate Devinnova's connected patch in different locations: post-interventional surveillance room that approaches a conventional hospital room, operating room where artifacts are numerous.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Connected patch validationConnected patch validation
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Validation of a Connected Patch, an Alternative to Conventional Monitoring
Actual Study Start Date :
Dec 29, 2020
Anticipated Primary Completion Date :
May 29, 2022
Anticipated Study Completion Date :
Jun 3, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Connected patch validation

Device: Patch validation
Use of connected patch to collect blood pressure, heart rate, respiratory rate, arterial oxygen saturation and temperature

Outcome Measures

Primary Outcome Measures

  1. Concordance of blood pressure value measured by 2 different devices during the postoperative stay in the post-operative period in the post-anesthesia care unit [36 hours maximum after the surgery]

    Comparison between blood pressure measured by conventional medical monitoring device and by connected patch

  2. Concordance of heart rate value measured by 2 different devices during the postoperative stay in the post-operative period in the post-anesthesia care unit [36 hours maximum after the surgery]

    Comparison between heart rate measured by conventional medical monitoring device and by connected patch

  3. Concordance of respiratory rate value measured by 2 different during the postoperative stay in the post-operative period in the post-anesthesia care unit [36 hours maximum after the surgery]

    Comparison between respiratory rate measured by conventional medical monitoring device and by connected patch

  4. Concordance of arterial oxygen saturation value measured by 2 different devices during the postoperative stay in the post-operative period in the post-anesthesia [36 hours maximum after the surgery]

    Comparison between arterial oxygen saturation measured by conventional medical monitoring device and by connected patch

  5. Concordance of temperature value measured by 2 different devices during the postoperative stay in the post-operative period in the post-anesthesia care unit [36 hours maximum after the surgery]

    Comparison between temperature measured by conventional medical monitoring device and by connected patch

Secondary Outcome Measures

  1. Concordance of blood pressure value measured by 2 different devices during anesthesia [During anesthesia]

    Comparison between blood pressure measured by conventional medical monitoring device and by connected patch

  2. Concordance of heart rate value measured by 2 different devices during anesthesia [During anesthesia]

    Comparison between heart rate measured by conventional medical monitoring device and by connected patch

  3. Concordance of respiratory rate value measured by 2 different devices during anesthesia [During anesthesia]

    Comparison between respiratory rate measured by conventional medical monitoring device and by connected patch

  4. Concordance of arterial oxygen saturation value measured by 2 different devices during anesthesia [During anesthesia]

    Comparison between arterial oxygen saturation measured by conventional medical monitoring device and by connected patch

  5. Concordance of temperature value measured by 2 different devices during anesthesia [During anesthesia]

    Comparison between temperature value measured by conventional medical monitoring device and by connected patch

  6. Blood pressure artifact [From beginning of anesthesia to 36 hours]

    An artifact is defined as any value that deviates from a physiologically plausible range or by a deviation > 50% from the previous value unless this value is followed by a value equal to ± 25%

  7. Heart rate artifact [From beginning of anesthesia to 36 hours maximum after the surgery]

    An artifact is defined as any value that deviates from a physiologically plausible range or by a deviation > 50% from the previous value unless this value is followed by a value equal to ± 25%

  8. Respiratory rate artifact [From beginning of anesthesia to 36 hours maximum after the surgery]

    An artifact is defined as any value that deviates from a physiologically plausible range or by a deviation > 50% from the previous value unless this value is followed by a value equal to ± 25%

  9. Arterial oxygen saturation artifact [From beginning of anesthesia to 36 hours maximum after the surgery]

    An artifact is defined as any value that deviates from a physiologically plausible range or by a deviation > 50% from the previous value unless this value is followed by a value equal to ± 25%

  10. Acceptability of connected patch [During the surgery and 36 hours maximum after the surgery]

    The patient will be asked to evaluate its acceptance of the sensor using a 4-point Likert scale (from 0 = intolerable to 4 = no problem at all)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patient over 18 and under 85 years of age

  • patient requiring general anesthesia for extra-thoracic surgery

  • the patient's position during the operation is in supine position only

  • patient affiliated to or benefiting from social security, excluding State Medical Assistance

  • patient with written consent

Exclusion Criteria:
  • pregnant or breastfeeding patients

  • patients known to have severe skin reactions to adhésives

  • patient whose surgical procedure prevents the patch from being placed (intervention on the thorax)

  • patients deprived of their liberty or under guardianship

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital FOCH Suresnes France

Sponsors and Collaborators

  • CMC Ambroise Paré

Investigators

  • Study Chair: Marc FISCHLER, MD, Hopital Foch

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CMC Ambroise Paré
ClinicalTrials.gov Identifier:
NCT04344093
Other Study ID Numbers:
  • 2019/11
First Posted:
Apr 14, 2020
Last Update Posted:
May 7, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 7, 2021